chr22-26292417-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000248933.11(SEZ6L):c.106G>A(p.Glu36Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000109 in 1,612,398 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000248933.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEZ6L | NM_021115.5 | c.106G>A | p.Glu36Lys | missense_variant | 2/17 | ENST00000248933.11 | NP_066938.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEZ6L | ENST00000248933.11 | c.106G>A | p.Glu36Lys | missense_variant | 2/17 | 1 | NM_021115.5 | ENSP00000248933 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000129 AC: 32AN: 248016Hom.: 0 AF XY: 0.0000895 AC XY: 12AN XY: 134108
GnomAD4 exome AF: 0.000110 AC: 161AN: 1460156Hom.: 1 Cov.: 30 AF XY: 0.000134 AC XY: 97AN XY: 726342
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74424
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2023 | The c.106G>A (p.E36K) alteration is located in exon 2 (coding exon 2) of the SEZ6L gene. This alteration results from a G to A substitution at nucleotide position 106, causing the glutamic acid (E) at amino acid position 36 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at